The viral serpin SPI-1 directly inhibits the host cell serine protease FAM111A
The host-range mutant of rabbitpox virus (RPXV) with a deletion in the gene encoding the serpin serine protease inhibitor 1 (SPI-1) fails to replicate efficiently in restrictive host cells. Depletion of the host cell serine protease FAM111A restores viral replication in these cells, suggesting that SPI-1 targets FAM111A to facilitate infection. However, direct evidence of SPI-1 inhibiting FAM111A has been lacking. Here, we demonstrate that SPI-1 directly inhibits FAM111A's protease activity in vitro through covalent complex formation, a hallmark of the serpin inhibition mechanism. SPI-1 also exhibits specificity for FAM111A compared to other serine proteases in vitro. Through mutagenesis studies, we identified residues and regions within SPI-1's reactive center loop (RCL) that are critical for FAM111A inhibition and covalent complex formation in vitro, with varying degrees of impact. Notably, these RCL mutations showed a spectrum of effects on SPI-1's ability to support RPXV replication in non-permissive cells, which strongly correlated with their impact on SPI-1's capacity to inhibit FAM111A activity in vitro. Altogether, our study provides direct evidence that SPI-1 inhibits FAM111A protease activity, highlighting FAM111A's antiviral role and its significance as a target of SPI-1 during orthopoxvirus infection.
Authors
- Matthew J. Schellenberg (ORCID: https://orcid.org/0000-0001-7036-5943)
- Sowmiya Palani (ORCID: https://orcid.org/0000-0001-8057-6058)
- Allison L Welter (ORCID: https://orcid.org/0000-0001-6132-8737)
- Yuichi Machida (ORCID: https://orcid.org/0000-0003-1414-0568)
- Yuka Machida
Institutions
- Mayo Clinic (US)
- WinnMed (US)
- National Cancer Institute (UA)
- National Cancer Institute (US)
Publication Details
- Journal
- Journal of Biological Chemistry
- Published
- 2025-01-10
- DOI
- https://doi.org/10.1016/j.jbc.2025.108175
- Citations
- 1
- Primary Topic
- Virus-based gene therapy research
- Type
- article
- Field-Weighted Citation Impact
- 1.82
Funders
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases